Single-use devices not suitable for reprocessing, says EU scientific panel
This article was originally published in RAJ Devices
Reprocessing of single-use medical devices (SUDs) may pose several potential hazards and put patients at risk, the European Commission’s independent Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) has concluded1.
You may also be interested in...
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Twenty-four guidance documents have been posted on the tracker since its last update.
The risk of psychiatric disorders with chloroquine and hydroxychloroquine-containing medicines received renewed attention in the EU after they were being used as potential treatments for COVID-19.
New UK guidance explains how clinical trial sponsors and investigator sites can ensure that trial monitors securely process data in electronic health record systems that do not have a restricted access functionality.